Prevalence of Nonalcoholic Fatty Liver Disease in Type 1 Diabetes Mellitus and Utility of Noninvasive Tests | Synapse
April 19, 2026
Prevalence of Nonalcoholic Fatty Liver Disease in Type 1 Diabetes Mellitus and Utility of Noninvasive Tests
Puntos clave
To determine the prevalence of nonalcoholic fatty liver disease (NAFLD) in individuals with type 1 diabetes mellitus and evaluate the effectiveness of noninvasive tests.
Conducted an observational study on individuals with type 1 diabetes.
Assessed the prevalence of NAFLD using specific diagnostic criteria.
Utilized noninvasive tests including FIB-4 score for evaluation.
NAFLD was found in approximately 25% of individuals with type 1 diabetes.
Lower FIB-4 scores were identified as potential indicators for screening this population.
Resumen
NAFLD was observed in nearly one-quarter of individuals. NITs, including a lower FIB-4 score, could aid in screening this high-risk population.